Adaptive Biotechnologies Corporation
$26.25
+0.70 (+2.74%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +16.5%
- 3 Months
- +85.8%
- YTD
- +61.6%
- 1 Year
- +101.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 69.0%
- Largest decline max drawdown, since Aug 2025
- -39.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.36
Own ADPT?
See how ADPT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.